Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 493 articles:
HTML format



Single Articles


    May 2020
  1. TABAZA L, Virk HUH, Janzer S, George JC, et al
    Robotic-assisted percutaneous coronary intervention in a COVID-19 patient.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28982.
    PubMed     Abstract available


  2. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  3. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  4. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  5. XIONG TY, Liao YB, Li YJ, Chen F, et al
    Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28903.
    PubMed     Abstract available


  6. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    PubMed     Abstract available


  7. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  8. VIRK HUH, Lakhter V, Tabaza L, George JC, et al
    Do we need robotics for coronary intervention more than ever in the COVID-19 era?
    Catheter Cardiovasc Interv. 2020 May 7. doi: 10.1002/ccd.28949.
    PubMed    


  9. VEULEMANS V, Maier O, Bosbach G, Polzin A, et al
    Novel insights on outcome in horizontal aorta with self-expandable new-generation transcatheter aortic valve replacement devices.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28961.
    PubMed     Abstract available


  10. EL-SABAWI B, Guerrero ME, Eleid MF, Rihal CS, et al
    Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28944.
    PubMed     Abstract available


  11. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


    April 2020
  12. MISUMIDA N, Anderson JH, Greason KL, Rihal CS, et al
    Antegrade transseptal transcatheter aortic valve replacement: Back to the future?
    Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28934.
    PubMed     Abstract available


  13. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  14. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28928.
    PubMed     Abstract available


  15. SADEGHIPOUR P, Talasaz AH, Eslami V, Gerayeli B, et al
    Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Apr 22. doi: 10.1002/ccd.28889.
    PubMed     Abstract available


  16. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  17. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


  18. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  19. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28904.
    PubMed     Abstract available


  20. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  21. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed     Abstract available


  22. TARANTINI G, Fabris T
    Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.
    Catheter Cardiovasc Interv. 2020;95:991-992.
    PubMed     Abstract available


  23. KATARUKA A, Dean LS
    Uncommon but devastating: Stroke after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020;95:893-894.
    PubMed     Abstract available


    March 2020
  24. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  25. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    PubMed     Abstract available


  26. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  27. SCHUELER R, Ozturk C, Laser JV, Wirth F, et al
    Right ventricular assessment in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28861.
    PubMed     Abstract available


  28. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    PubMed     Abstract available


  29. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Response to: Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28828.
    PubMed    


  30. IMAMURA T
    Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28829.
    PubMed    


  31. HENSEY M, Sathananthan J, Alkhodair A, Landes U, et al
    Single-center prospective study examining use of the Wattson temporary pacing guidewire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 9. doi: 10.1002/ccd.28832.
    PubMed     Abstract available


  32. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  33. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  34. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    PubMed     Abstract available


  35. KHAN MZ, Khan MU, Munir MB, Khan SU, et al
    Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28834.
    PubMed     Abstract available


  36. ROWIN EJ, Kimmelstiel C
    Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire.
    Catheter Cardiovasc Interv. 2020;95:838-839.
    PubMed     Abstract available


    February 2020
  37. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    PubMed     Abstract available


  38. HUDED CP, Kapadia SR, Ballout JA, Krishnaswamy A, et al
    Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28785.
    PubMed     Abstract available


  39. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  40. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available


  41. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  42. AHMED A, Alsidawi S, Bae R, Cavalcante J, et al
    Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28805.
    PubMed     Abstract available


  43. REIFF C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, et al
    3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28783.
    PubMed     Abstract available


  44. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  45. AYYOUB A, Levy MS
    Mechanical circulatory support in high-risk percutaneous coronary intervention: IIb or not IIb?
    Catheter Cardiovasc Interv. 2020;95:513-514.
    PubMed    


  46. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    PubMed     Abstract available


    January 2020
  47. MAHMUD E
    The COMPLETE and ISCHEMIA trials: Two contemporary studies showing percutaneous coronary intervention reduces the risk of myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Jan 29. doi: 10.1002/ccd.28723.
    PubMed    


  48. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  49. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  50. BANDYOPADHYAY D, Sartori S, Baber U, Cao D, et al
    The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28752.
    PubMed     Abstract available


  51. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    PubMed     Abstract available


  52. YOU J, Li H, Guo W, Li J, et al
    Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28712.
    PubMed     Abstract available


  53. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  54. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  55. GILCHRIST IC
    Gastrointestinal bleeding after percutaneous coronary intervention: Not just a short-term complication but a long-term marker of mortality risk.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28680.
    PubMed     Abstract available


  56. TABACHNICK D, Obokhae B, Harrington K, Brown DL, et al
    Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28695.
    PubMed     Abstract available


  57. ZHAO ZG, Feng Y, Liao YB, Li YJ, et al
    Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: A pilot study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28726.
    PubMed     Abstract available


  58. CAMAJ A, Claessen BE, Mehran R, Yudi MB, et al
    The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
    Catheter Cardiovasc Interv. 2020 Jan 13. doi: 10.1002/ccd.28717.
    PubMed     Abstract available


  59. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  60. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  61. ZHAO X, Li J, Xian Y, Chen J, et al
    Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28719.
    PubMed     Abstract available


  62. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28696.
    PubMed     Abstract available


  63. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


    December 2019
  64. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


  65. GAO G, Zhang D, Song C, Xu H, et al
    Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28673.
    PubMed     Abstract available


  66. LI J, Li Y, Qiu M, Li Z, et al
    Impact of dual antiplatelet therapy duration on 1-year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28653.
    PubMed     Abstract available


  67. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  68. YAN L, Li P, Wang Y, Han D, et al
    Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28652.
    PubMed     Abstract available


  69. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  70. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    PubMed     Abstract available


  71. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  72. RIANGWIWAT T, Mumtaz T, Blankenship JC
    Barriers to use of radial access for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28619.
    PubMed     Abstract available


  73. ALI Z, Sharma P, Mengesha T, Dalmar A, et al
    Early clinical and procedural outcomes in large series of 34-mm self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28634.
    PubMed     Abstract available


  74. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


  75. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


    November 2019
  76. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  77. OMRAN J, Enezate T, Abdullah O, Al-Dadah A, et al
    Outcomes of fractional flow reserve-guided percutaneous coronary interventions in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28611.
    PubMed     Abstract available


  78. KOTRONIAS RA, Scarsini R, De Maria GL, Rajasundaram S, et al
    Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: Insights from the OxTAVI registry.
    Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28578.
    PubMed     Abstract available


  79. ASHLEY KE, Hillegass WB
    Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
    Catheter Cardiovasc Interv. 2019;94:818-819.
    PubMed     Abstract available


  80. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  81. FUGAR S, Behnamfar O, Okoh AK, Alabre AF, et al
    Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28519.
    PubMed     Abstract available


  82. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  83. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  84. SULLIVAN AE, Nanna MG, Rao SV, Cantrell S, et al
    A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28535.
    PubMed     Abstract available


  85. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


  86. PAREKH DR, Krajcer Z
    Transapical transcatheter aortic valves. Down but definitely not out for the count.
    Catheter Cardiovasc Interv. 2019;94:745.
    PubMed    


    October 2019
  87. BATCHELOR R, Liu DH, Bloom J, Noaman S, et al
    Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 26. doi: 10.1002/ccd.28561.
    PubMed     Abstract available


  88. ELBADAWI A, Elgendy IY, Mentias A, Saad M, et al
    Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28563.
    PubMed     Abstract available


  89. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  90. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  91. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  92. GOEL S, Pasam RT, Wats K, Patel J, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28520.
    PubMed     Abstract available


  93. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available


  94. SINHA S, Khan A, Qureshi AM, Suh W, et al
    Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28505.
    PubMed     Abstract available


  95. POLETTI E, Azzalini L, Ayoub M, Ojeda S, et al
    Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.
    Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513.
    PubMed     Abstract available


    September 2019
  96. DOWLING C, Kondapally Seshasai SR, Firoozi S, Brecker SJ, et al
    Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28504.
    PubMed     Abstract available


  97. HELMY T, Hui DS, Smart S, Lim MJ, et al
    Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2019 Sep 13. doi: 10.1002/ccd.28496.
    PubMed     Abstract available


  98. STAUDACHER DL, Schmitt C, Zirlik A, Zehender M, et al
    Predictors of survival in patients with acute coronary syndrome undergoing percutaneous coronary intervention of unprotected left main coronary artery stenosis.
    Catheter Cardiovasc Interv. 2019 Sep 11. doi: 10.1002/ccd.28495.
    PubMed     Abstract available


  99. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


  100. ATTINGER-TOLLER A, Bhindi R, Perlman GY, Murdoch D, et al
    Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28475.
    PubMed     Abstract available


  101. ZHONG C, Rokey R, Rolak S, Mesa J, et al
    Pregnancy and transcatheter aortic valve replacement in a severely stenotic Freestyle full aortic root stentless bioprosthesis.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28481.
    PubMed     Abstract available


  102. HIRAI T, Kearney K, Kataruka A, Gosch KL, et al
    Initial report of safety and procedure duration of robotic-assisted chronic total occlusion coronary intervention.
    Catheter Cardiovasc Interv. 2019 Sep 4. doi: 10.1002/ccd.28477.
    PubMed     Abstract available


  103. TARANTINI G, Giacoppo D
    Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery?
    Catheter Cardiovasc Interv. 2019;94:385-386.
    PubMed     Abstract available


  104. KORNOWSKI R
    Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.
    Catheter Cardiovasc Interv. 2019;94:446-447.
    PubMed     Abstract available


  105. CILINGIROGLU M, Margmakiolis K
    Predilatation for transcatheter aortic valve replacement: Still have a role?
    Catheter Cardiovasc Interv. 2019;94:479-480.
    PubMed     Abstract available


  106. ZAHR F, Cigarroa JE
    Replacing the mitral valve alone does not completely fix the heart!
    Catheter Cardiovasc Interv. 2019;94:467-468.
    PubMed     Abstract available


  107. MUSUMECI G, Cinconze S
    Relationship volume-outcome for transcatheter mitral-valve repair: When technique matters.
    Catheter Cardiovasc Interv. 2019;94:436-437.
    PubMed     Abstract available


    August 2019
  108. EUDAILEY KW, Olds A, Lewis CT, Nazif TN, et al
    Contemporary suprasternal transcatheter aortic valve replacement: A multicenter experience using a simple, reliable alternative access approach.
    Catheter Cardiovasc Interv. 2019 Aug 26. doi: 10.1002/ccd.28460.
    PubMed     Abstract available


  109. KANDZARI DE, Karmpaliotis D, Kini AS, Moses JW, et al
    Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPER
    Catheter Cardiovasc Interv. 2019 Aug 24. doi: 10.1002/ccd.28436.
    PubMed     Abstract available


  110. GOEL S, Pasam RT, Raheja H, Gotesman J, et al
    Left main percutaneous coronary intervention-Radial versus femoral access: A systematic analysis.
    Catheter Cardiovasc Interv. 2019 Aug 20. doi: 10.1002/ccd.28451.
    PubMed     Abstract available


  111. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Aug 18. doi: 10.1002/ccd.28440.
    PubMed     Abstract available


  112. ANANTHA-NARAYANAN M, Malik U, Mbai M, Megaly M, et al
    Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 16. doi: 10.1002/ccd.28444.
    PubMed     Abstract available


  113. POTTS J, Mohamed MO, Lopez Mattei JC, Iliescu CA, et al
    Percutaneous coronary intervention and in-hospital outcomes in patients with leukemia: a nationwide analysis.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28432.
    PubMed     Abstract available


  114. KOGAME N, Chichareon P, De Wilder K, Takahashi K, et al
    Clinical relevance of ticagrelor monotherapy following 1-month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28428.
    PubMed     Abstract available


  115. ROULE V, Schwob L, Lemaitre A, Bignon M, et al
    Residual atherothrombotic burden after primary percutaneous coronary intervention and myocardial reperfusion-An optical frequency domain imaging study.
    Catheter Cardiovasc Interv. 2019 Aug 13. doi: 10.1002/ccd.28429.
    PubMed     Abstract available


  116. DOSHI R, Patel K, Desai R, Patel P, et al
    Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28431.
    PubMed     Abstract available


  117. IANNACCONE M, Abdirashid M, Annone U, Saint-Hilary G, et al
    Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention: A network meta-analysis of randomized and propensity matching studies.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28410.
    PubMed     Abstract available


  118. KAMPAKTSIS PN, Vavuranakis M, Choi DY, Sherifi I, et al
    Prognostic role of diastolic dysfunction in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Aug 9. doi: 10.1002/ccd.28426.
    PubMed     Abstract available


  119. WATANABE H, Shiomi H, Morimoto T, Furukawa Y, et al
    Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Catheter Cardiovasc Interv. 2019 Aug 7. doi: 10.1002/ccd.28420.
    PubMed     Abstract available


    July 2019
  120. FLAHERTY MP, Moses JW, Westenfeld R, Palacios I, et al
    Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400.
    PubMed     Abstract available


  121. CASTRO-MEJIA AF, Ortega-Armas ME, Mejia-Renteria H, Gonzalo N, et al
    Short-term clinical outcomes of percutaneous coronary intervention of unprotected left main coronary disease in cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jul 26. doi: 10.1002/ccd.28404.
    PubMed     Abstract available


  122. KAR S
    Systematic review of alternative access for cardiac catheterization and percutaneous coronary intervention: Dorsal distal radial and ulnar artery catheterization.
    Catheter Cardiovasc Interv. 2019 Jul 22. doi: 10.1002/ccd.28398.
    PubMed     Abstract available


  123. GASPARINI GL, Garbo R, Gagnor A, Oreglia J, et al
    Feasibility and safety of distal radial access for percutaneous coronary intervention using a 7 FR sheath.
    Catheter Cardiovasc Interv. 2019 Jul 21. doi: 10.1002/ccd.28397.
    PubMed    


  124. SAADAT N, Saadatagah S, Aghajani Nargesi A, Alidoosti M, et al
    Short-term safety and long-term benefits of stent postdilation after primary percutaneous coronary intervention: Results of a cohort study.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28396.
    PubMed     Abstract available


  125. LI Y, Tian F, Wang J, Xie M, et al
    Pseudoaneurysm of the non-coronary sinus of Valsalva: A rare complication of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jul 18. doi: 10.1002/ccd.28407.
    PubMed     Abstract available


  126. PINO JE, Shah V, Ramos Tuarez FJ, Kreidieh OI, et al
    The utility of pulmonary function testing in the preoperative risk stratification of patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28402.
    PubMed     Abstract available


  127. RAFEEDHEEN R, Agarwal SK, Meek JC, Uretsky BF, et al
    Use of "super-glue" to seal a perforation during chronic total occlusion coronary intervention and the potential to "unglue" it.
    Catheter Cardiovasc Interv. 2019 Jul 16. doi: 10.1002/ccd.28399.
    PubMed     Abstract available


  128. KIRTANE AJ, Yeung AC, Ball M, Carr J, et al
    Long-term (5-year) clinical evaluation of the Resolute zotarolimus-eluting coronary stent: The RESOLUTE US clinical trial.
    Catheter Cardiovasc Interv. 2019 Jul 13. doi: 10.1002/ccd.28392.
    PubMed     Abstract available


    June 2019
  129. HE Y, Cheng XF, Wang K, Liu T, et al
    Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 29. doi: 10.1002/ccd.28384.
    PubMed     Abstract available


  130. AL-KHADRA Y, Alraies MC, Darmoch F, Pacha HM, et al
    Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Jun 28. doi: 10.1002/ccd.28383.
    PubMed     Abstract available


  131. HIRAI T, Jacob D, Main ML, Grantham JA, et al
    A case of robotic assisted percutaneous coronary intervention of the left main coronary artery in a patient with very late baffle stenosis after surgical correction of anomalous left coronary artery from the pulmonary artery.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28382.
    PubMed     Abstract available


  132. SHAH R, Naz A
    Postprocedure bivalirudin infusion for primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 26. doi: 10.1002/ccd.28377.
    PubMed    


  133. NANJUDAPPA A, Bhagat A, Bates MC
    A rare cause of stroke after transcatheter aortic valve replacement: Retained foreign body.
    Catheter Cardiovasc Interv. 2019 Jun 24. doi: 10.1002/ccd.28374.
    PubMed     Abstract available


  134. CHANDIRAMANI R, Chen H, Aoi S, Giustino G, et al
    Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369.
    PubMed     Abstract available


  135. CHEN W, Lu D, Huang Z, Xiao L, et al
    Is a prolongation of bivalirudin infusion needed in patients with STEMI undergoing percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2019 Jun 10. doi: 10.1002/ccd.28368.
    PubMed    


  136. KEYMEL S, Papadopoulos G, Minol JP, Blehm A, et al
    Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28358.
    PubMed     Abstract available


  137. TRIPATHI B, Yeh RW, Bavishi CP, Sardar P, et al
    Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28344.
    PubMed     Abstract available


  138. STACHON P, Kaier K, Heidt T, Bothe W, et al
    Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361.
    PubMed     Abstract available


  139. PRICE DJ, Levy MS
    CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone?
    Catheter Cardiovasc Interv. 2019;93:1253-1254.
    PubMed     Abstract available


  140. BLOCK PC, Lisko JC
    Thrombocytopenia after transcatheter aortic valve replacement: What is really going on?
    Catheter Cardiovasc Interv. 2019;93:1352-1353.
    PubMed     Abstract available


    May 2019
  141. MONTERO CABEZAS JM, Abou R, Goedemans L, Aguero J, et al
    Procedural-related coronary atrial branch occlusion during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and atrial arrhythmias at follow-up.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28351.
    PubMed     Abstract available


  142. AMAT-SANTOS IJ, Gutierrez H, Sathananthan J, Webb JG, et al
    Fracture of small Mitroflow(R) aortic bioprosthesis following valve-in-valve transcatheter aortic valve replacement with ACURATE neo valve-From bench testing to clinical practice.
    Catheter Cardiovasc Interv. 2019 May 29. doi: 10.1002/ccd.28347.
    PubMed     Abstract available


  143. KIM N, Lee JH, Jang SY, Bae MH, et al
    Intravascular modality-guided versus angiography-guided percutaneous coronary intervention in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2019 May 27. doi: 10.1002/ccd.28359.
    PubMed     Abstract available


  144. CHEN Y, Yin T, Xi S, Zhang S, et al
    A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28325.
    PubMed     Abstract available


  145. KOYAMA Y, Yamamoto M, Kagase A, Tsujimoto S, et al
    Prognostic impact and periprocedural complications of chronic steroid therapy in patients following transcatheter aortic valve replacement: Propensity-matched analysis from the Japanese OCEAN registry.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28332.
    PubMed     Abstract available


  146. BARBARAWI M, Kheiri B, Zayed Y, Barbarawi O, et al
    Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2019 May 21. doi: 10.1002/ccd.28280.
    PubMed     Abstract available


  147. DESCH S, Thiele H
    Letter commenting on: Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis (Kundu et al. Catheter Cardio
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28331.
    PubMed    


  148. KUNDU A, Sardar P, Kakouros N, Fisher DZ, et al
    Rebuttal: Response to letter by Desch et al. regarding "Outcomes of multivessel vs. culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-ana
    Catheter Cardiovasc Interv. 2019 May 15. doi: 10.1002/ccd.28334.
    PubMed    


  149. IBRAHIM H, Vapheas E, Shah B, AlKhalil A, et al
    Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28320.
    PubMed     Abstract available


  150. SEKIGUCHI M, Muramatsu T, Kishi K, Muto M, et al
    Assessment of reattempted percutaneous coronary intervention strategy for chronic total occlusion after prior failed procedures: Analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2019 May 6. doi: 10.1002/ccd.28315.
    PubMed     Abstract available


  151. KARATASAKIS A, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention failure: Learning from failure.
    Catheter Cardiovasc Interv. 2019;93:1039-1040.
    PubMed     Abstract available


  152. KALYANASUNDARAM A, Seth A
    Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care?
    Catheter Cardiovasc Interv. 2019;93:1067-1068.
    PubMed     Abstract available


  153. ASHLEY KE, Hillegass WB
    Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.
    Catheter Cardiovasc Interv. 2019;93:1137.
    PubMed     Abstract available


    April 2019
  154. JUNQUERA L, Freitas-Ferraz AB, Padron R, Silva I, et al
    Intraprocedural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement recipients with no prior intraventricular conduction disturbances.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28323.
    PubMed     Abstract available


  155. SEPPELT PC, Zappel J, Weiler H, Mas-Peiro S, et al
    Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Catheter Cardiovasc Interv. 2019 Apr 29. doi: 10.1002/ccd.28319.
    PubMed     Abstract available


  156. MOHANANEY D, Villablanca P, Gupta T, Ranka S, et al
    Association of peripheral artery disease with in-hospital outcomes after endovascular transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28310.
    PubMed     Abstract available


  157. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Mendez-Bailon M, et al
    Impact of COPD on outcomes in hospitalized patients treated with transcatheter aortic valve implantation or surgical aortic valve replacement in Spain.
    Catheter Cardiovasc Interv. 2019 Apr 25. doi: 10.1002/ccd.28321.
    PubMed     Abstract available


  158. VAN NUNEN LX, van 't Veer M, Zimmermann FM, Wijnbergen I, et al
    Intra-aortic balloon pump counterpulsation in extensive myocardial infarction with persistent ischemia: The SEMPER FI pilot study.
    Catheter Cardiovasc Interv. 2019 Apr 24. doi: 10.1002/ccd.28289.
    PubMed     Abstract available


  159. RAJ L, Mehra A, Shavelle DM
    Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.
    Catheter Cardiovasc Interv. 2019 Apr 10. doi: 10.1002/ccd.28221.
    PubMed     Abstract available


  160. KWOK CS, Sirker A, Farmer AD, Kontopantelis E, et al
    In-hospital gastrointestinal bleeding following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Apr 8. doi: 10.1002/ccd.28222.
    PubMed     Abstract available


    March 2019
  161. AKTUERK D, Jansz P, Shaw M, Muller DWM, et al
    Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28210.
    PubMed     Abstract available


  162. SAIA F, Palmerini T, Compagnone M, Battistini P, et al
    Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Mar 27. doi: 10.1002/ccd.28211.
    PubMed     Abstract available


  163. ABAWI M, van Gils L, Agostoni P, van Mieghem NM, et al
    Impact of baseline cigarette smoking status on clinical outcome after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Mar 22. doi: 10.1002/ccd.28175.
    PubMed     Abstract available


  164. BELARDI JA, Lamelas PM
    Transcatheter aortic valve replacement hemodynamic durability: Still in question?
    Catheter Cardiovasc Interv. 2019;93:739.
    PubMed     Abstract available


  165. KUMAR V, Seth A
    Transcatheter aortic valve replacement: Protect the kidneys to protect the patient.
    Catheter Cardiovasc Interv. 2019;93:749-750.
    PubMed     Abstract available


  166. SHATILA W, Krajcer Z
    Does single-valve surgery cause ischemia?
    Catheter Cardiovasc Interv. 2019;93:590-591.
    PubMed     Abstract available


  167. VETROVEC GW
    Expanding opportunities for stent optimization.
    Catheter Cardiovasc Interv. 2019;93:611-612.
    PubMed     Abstract available


  168. CLAESSEN BE, Mehran R
    Hope for the best, prepare for the worst: How to manage coronary perforations.
    Catheter Cardiovasc Interv. 2019;93:E255-E256.
    PubMed     Abstract available


  169. GILCHRIST IC
    Treating hemolysis due to perivalvular leaks: It is all about modifying micro-jets and not the volume of regurgitation.
    Catheter Cardiovasc Interv. 2019;93:720-721.
    PubMed     Abstract available


    February 2019
  170. UESHIMA D, Masiero G, Schiavo A, Badawy MRA, et al
    Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Catheter Cardiovasc Interv. 2019 Feb 28. doi: 10.1002/ccd.28124.
    PubMed     Abstract available


  171. ATTI V, Patel NJ, Kumar V, Tripathi B, et al
    Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Catheter Cardiovasc Interv. 2019 Feb 27. doi: 10.1002/ccd.28161.
    PubMed     Abstract available


  172. AL-OGAILI A, Fugar S, Okoh A, Kolkailah AA, et al
    Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28156.
    PubMed     Abstract available


  173. RAMZY J, Andrianopoulos N, Roberts L, Duffy SJ, et al
    Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28145.
    PubMed     Abstract available


  174. CHEN B, Dean LS
    HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?
    Catheter Cardiovasc Interv. 2019;93:E202-E203.
    PubMed     Abstract available


  175. KHAN A, Dangas G
    Positioning of self-expanding transcatheter valve prostheses.
    Catheter Cardiovasc Interv. 2019;93:530-531.
    PubMed     Abstract available


  176. PAREKH DR, Krajcer Z
    Percutaneous pulmonary valve implantation: It's not like the aortic valve.
    Catheter Cardiovasc Interv. 2019;93:464-465.
    PubMed     Abstract available


  177. BELARDI JA, Lamelas P
    Impella support for chronic total occlusions angioplasty: A good start.
    Catheter Cardiovasc Interv. 2019;93:E191-E192.
    PubMed     Abstract available


  178. DAVIDSON LJ, Davidson CJ
    CAD strategy in the TAVR era.
    Catheter Cardiovasc Interv. 2019;93:553-554.
    PubMed     Abstract available


  179. SETO AH, Kern MJ
    Every TAVR deserves a cardiac implantable electronic device specialist.
    Catheter Cardiovasc Interv. 2019;93:E200-E201.
    PubMed     Abstract available


  180. WOODY WW
    Radial first, radial second, and beyond.
    Catheter Cardiovasc Interv. 2019;93:562.
    PubMed    


  181. KIRTANE AJ
    Re-wire but don't necessarily kiss twice for bifurcations treated with two stents: The DR-crush technique.
    Catheter Cardiovasc Interv. 2019;93.
    PubMed    


  182. WANG Y, Zhao HW, Wang CF, Fan CY, et al
    Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2019 Feb 5. doi: 10.1002/ccd.28087.
    PubMed     Abstract available


  183. HARFOUCH B, Prasad A
    The use of ultra low contrast volume during percutaneous coronary intervention and risk of acute kidney injury: How low can we go?
    Catheter Cardiovasc Interv. 2019;93:231-232.
    PubMed     Abstract available


  184. HALL AB, Brilakis ES
    Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019;93:199-201.
    PubMed     Abstract available


  185. BELARDI J, Lamelas P
    TAVR for aortic valve regurgitation: Ready for a randomized trial?
    Catheter Cardiovasc Interv. 2019;93:354-355.
    PubMed     Abstract available


  186. GOLESKI PJ, Nakamura K, Liebeskind E, Salisbury AC, et al
    Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: Experience from a high-volume referral center.
    Catheter Cardiovasc Interv. 2019;93:191-198.
    PubMed     Abstract available


  187. MORGAN GJ, Sadeghi S, Salem MM, Wilson N, et al
    SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:324-329.
    PubMed     Abstract available


  188. ROSENBERG M, Waliszewski M, Chin K, Ahmad WAW, et al
    Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry.
    Catheter Cardiovasc Interv. 2019;93:181-188.
    PubMed     Abstract available


  189. CLAESSEN BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, et al
    Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: Insights from the randomized DARE trial.
    Catheter Cardiovasc Interv. 2019;93:216-221.
    PubMed     Abstract available


  190. BLACHUTZIK F, Achenbach S, Trobs M, Marwan M, et al
    Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2019;93:202-207.
    PubMed     Abstract available


  191. INGRASSIA J, Youn YJ, Lee J, Azrin M, et al
    Novel approach to coronary artery perforation repair.
    Catheter Cardiovasc Interv. 2019;93:E98-E100.
    PubMed     Abstract available


    January 2019
  192. RUBIMBURA V, Rostain L, Duval AM, Akakpo S, et al
    Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study.
    Catheter Cardiovasc Interv. 2019 Jan 31. doi: 10.1002/ccd.28084.
    PubMed     Abstract available


  193. WU K, Huang Z, Zhong Z, Liao H, et al
    Predictors, treatment, and long-term outcomes of coronary perforation during retrograde percutaneous coronary intervention via epicardial collaterals for recanalization of chronic coronary total occlusion.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28093.
    PubMed     Abstract available


  194. REED GW, Rossi JE, Masri A, Griffin BP, et al
    Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease.
    Catheter Cardiovasc Interv. 2019 Jan 28. doi: 10.1002/ccd.28107.
    PubMed     Abstract available


  195. AL-HIJJI MA, Zack CJ, Nkomo VT, Pislaru SV, et al
    Left ventricular remodeling and function after transapical versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Jan 27. doi: 10.1002/ccd.28074.
    PubMed     Abstract available


  196. SHARMA SK, Bolduan RW, Patel MR, Martinsen BJ, et al
    Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28099.
    PubMed     Abstract available


  197. RATTANAWONG P, Kanitsoraphan C, Kewcharoen J, Riangwiwat T, et al
    Chronic kidney disease is associated with increased mortality and procedural complications in transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2019 Jan 25. doi: 10.1002/ccd.28102.
    PubMed     Abstract available


  198. FAGGIONI M, Baber U, Chandrasekhar J, Sartori S, et al
    Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2019 Jan 17. doi: 10.1002/ccd.28033.
    PubMed     Abstract available


  199. JIA S, Zhao Y, Yang J, Zhao X, et al
    Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Catheter Cardiovasc Interv. 2019 Jan 13. doi: 10.1002/ccd.28060.
    PubMed     Abstract available


  200. KHEIRI B, Abdalla A, Osman M, Barbarawi M, et al
    Personalized antiplatelet therapy in patients with coronary artery disease undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28075.
    PubMed     Abstract available


  201. POTTS J, Nagaraja V, Al Suwaidi J, Brugaletta S, et al
    The influence of Elixhauser comorbidity index on percutaneous coronary intervention outcomes.
    Catheter Cardiovasc Interv. 2019 Jan 10. doi: 10.1002/ccd.28072.
    PubMed     Abstract available


  202. WANG H, Ning X, Zhu C, Yin D, et al
    Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28057.
    PubMed     Abstract available


  203. OKOH AK, Haik N, Singh S, Kaur K, et al
    Discharge disposition of older patients undergoing trans-catheter aortic valve replacement and its impact on survival.
    Catheter Cardiovasc Interv. 2019 Jan 7. doi: 10.1002/ccd.28069.
    PubMed     Abstract available


  204. CHAN CY, Wu EB, Yan BP, Tsuchikane E, et al
    Procedure failure of chronic total occlusion percutaneous coronary intervention in an algorithm driven contemporary Asia-Pacific Chronic Total Occlusion Club (APCTO Club) multicenter registry.
    Catheter Cardiovasc Interv. 2019 Jan 3. doi: 10.1002/ccd.28064.
    PubMed     Abstract available


  205. AHN SG, Lee JW, Youn YJ, Lee SH, et al
    In-hospital outcome differences between transradial and transfemoral coronary approaches: Data from the Korean percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2019 Jan 2. doi: 10.1002/ccd.28032.
    PubMed     Abstract available


  206. GIRI JS, Szerlip M, Devireddy C, Cox DA, et al
    SCAI 2018 Think Tank Proceedings: "What should the role of the surgeon be in TAVR, both as a co-operator and in-patient evaluation for TAVR?
    Catheter Cardiovasc Interv. 2019;93:178-179.
    PubMed    


  207. ALDERWEIRELDT AS, De Wolf D
    Percutaneous closure of paravalvular leak after Cone repair for Ebstein's anomaly.
    Catheter Cardiovasc Interv. 2019;93:E46-E48.
    PubMed     Abstract available


  208. SATHANANDAM S, Balduf K, Chilakala S, Washington K, et al
    Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants.
    Catheter Cardiovasc Interv. 2019;93:89-96.
    PubMed     Abstract available


  209. GARCIA-GUIMARAES M, Antuna P, Cuesta J, Alfonso F, et al
    Early restenosis of resorbable magnesium scaffolds: Optical coherence tomography findings.
    Catheter Cardiovasc Interv. 2019;93:79-81.
    PubMed     Abstract available


  210. FIOCCA L, Cereda AF, Bernelli C, Canova PA, et al
    Autologous blood reinfusion during iatrogenic acute hemorrhagic cardiac tamponade: Safety and feasibility in a cohort of 30 patients.
    Catheter Cardiovasc Interv. 2019;93:E56-E62.
    PubMed     Abstract available


  211. BAQUET M, Grundmann D, Schmidt W, Thienel M, et al
    Hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in KUM ABSORB registry.
    Catheter Cardiovasc Interv. 2019;93:71-78.
    PubMed     Abstract available


    December 2018
  212. CANNON LA, Kimmelstiel CD, White A, Hill R, et al
    Clinical outcomes following implantation of the ION paclitaxel-eluting platinum chromium coronary stent in routine clinical practice: Results of the ION U.S. post-approval study.
    Catheter Cardiovasc Interv. 2018 Dec 30. doi: 10.1002/ccd.28044.
    PubMed     Abstract available


  213. KUNDU A, Sardar P, Kakouros N, Malhotra R, et al
    Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Dec 28. doi: 10.1002/ccd.28062.
    PubMed     Abstract available


  214. CHOI CH, Cheng V, Malaver D, Kon N, et al
    A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28039.
    PubMed     Abstract available


  215. LIU S, Song C, Zhao Y, Guan C, et al
    Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28030.
    PubMed     Abstract available


  216. NEUPANE S, Khawaja O, Edla S, Singh H, et al
    Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28045.
    PubMed     Abstract available


  217. FABRIS E, Ottervanger JP, Hermanides RS, Ten Berg JM, et al
    Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Dec 26. doi: 10.1002/ccd.28043.
    PubMed     Abstract available


  218. ELGENDY IY, Mahmoud AN, Elbadwai A, Elgendy AY, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians.
    Catheter Cardiovasc Interv. 2018 Dec 19. doi: 10.1002/ccd.28050.
    PubMed     Abstract available


  219. POTTER BJ, Thompson C, Green P, Clancy S, et al
    Incremental cost and length of stay associated with postprocedure delirium in transcatheter and surgical aortic valve replacement patients in the United States.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28014.
    PubMed     Abstract available


  220. GAO G, Zhao Y, Zhang D, He Y, et al
    Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients?
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28053.
    PubMed     Abstract available


  221. SCHECHTER M, Balanescu DV, Donisan T, Dayah TJ, et al
    An update on the management and outcomes of cancer patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2018 Dec 14. doi: 10.1002/ccd.28052.
    PubMed     Abstract available


  222. IANNACCONE M, D'ascenzo F, Piazza F, De Benedictis M, et al
    Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.
    Catheter Cardiovasc Interv. 2018 Dec 13. doi: 10.1002/ccd.28037.
    PubMed     Abstract available


  223. CORCOS T
    Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Dec 11. doi: 10.1002/ccd.28016.
    PubMed     Abstract available


  224. ANDO T, Aoi S, Ashraf S, Villablanca PA, et al
    Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28025.
    PubMed     Abstract available


  225. FERNANDEZ-LOPEZ L, Chevalier B, Lefevre T, Spaziano M, et al
    Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center.
    Catheter Cardiovasc Interv. 2018 Dec 10. doi: 10.1002/ccd.28024.
    PubMed     Abstract available


  226. GUEDENEY P, Tchetche D, Petronio AS, Mehilli J, et al
    Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2018 Dec 4. doi: 10.1002/ccd.28012.
    PubMed     Abstract available


    November 2018
  227. YOUNIS A, Orvin K, Nof E, Barabash IM, et al
    The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 29. doi: 10.1002/ccd.28017.
    PubMed     Abstract available


  228. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27985.
    PubMed     Abstract available


  229. TAKAGI H, Hari Y, Kawai N, Ando T, et al
    Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.
    Catheter Cardiovasc Interv. 2018 Nov 25. doi: 10.1002/ccd.27948.
    PubMed     Abstract available


  230. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    An overview of percutaneous coronary intervention in dialysis patients: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27986.
    PubMed     Abstract available


  231. ABDELGHANI M, Allali A, Kaur J, Hemetsberger R, et al
    Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Nov 23. doi: 10.1002/ccd.27977.
    PubMed     Abstract available


  232. LEHNER A, Herrmann FE, Mehilli J, Haas NA, et al
    Edwards Sapien 3 transcatheter aortic valve implantation for management of severe aortic regurgitation in a teenage patient with corrected atrioventricular septal defect and progressive left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2018 Nov 20. doi: 10.1002/ccd.27975.
    PubMed     Abstract available


  233. WALTERS D, Reeves RR, Patel M, Naghi J, et al
    Complex robotic compared to manual coronary interventions: 6- and 12-month outcomes.
    Catheter Cardiovasc Interv. 2018 Nov 19. doi: 10.1002/ccd.27867.
    PubMed     Abstract available


  234. SCHUMACHER SP, Driessen RS, Stuijfzand WJ, Raijmakers PG, et al
    Recovery of myocardial perfusion after percutaneous coronary intervention of chronic total occlusions is comparable to hemodynamically significant non-occlusive lesions.
    Catheter Cardiovasc Interv. 2018 Nov 15. doi: 10.1002/ccd.27945.
    PubMed     Abstract available


  235. XU JJ, Song Y, Jiang P, Gao Z, et al
    Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.
    Catheter Cardiovasc Interv. 2018 Nov 13. doi: 10.1002/ccd.27705.
    PubMed     Abstract available


  236. GE J, Li J, Dong B, Ning X, et al
    Determinants of angiographic thrombus burden and impact of thrombus aspiration on outcome in young patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Nov 12. doi: 10.1002/ccd.27944.
    PubMed     Abstract available


  237. HABIB N, Mahmoodi BK, Suttorp MJ, Kelder JC, et al
    Long-term results of carotid stenting and risk factors in patients with severe carotid artery stenosis undergoing subsequent cardiac surgery.
    Catheter Cardiovasc Interv. 2018 Nov 9. doi: 10.1002/ccd.27947.
    PubMed     Abstract available


  238. SPINA R, Khalique O, Kodali S, Bapat VN, et al
    Urgent transcatheter aortic valve replacement for severe acute aortic regurgitation following open mitral valve surgery.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27954.
    PubMed     Abstract available


  239. ANDO T, Adegbala O, Villablanca PA, Briasoulis A, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in non-teaching hospitals.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27968.
    PubMed     Abstract available


  240. BUTTER C, Kaneko H, Tambor G, Hara M, et al
    Clinical utility of intraprocedural three-dimensional integrated image guided transcatheter aortic valve implantation using novel automated computed tomography software: A single-center preliminary experience.
    Catheter Cardiovasc Interv. 2018 Nov 8. doi: 10.1002/ccd.27920.
    PubMed     Abstract available


  241. DOWLING C, Firoozi S, Doyle N, Blackman DJ, et al
    Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2018 Nov 5. doi: 10.1002/ccd.27934.
    PubMed     Abstract available


  242. KUMAR A, Block PC
    Paravalvular leak after transcatheter aortic valve replacement: Avoid it or treat it if you can!
    Catheter Cardiovasc Interv. 2018;92:981-982.
    PubMed     Abstract available


    October 2018
  243. USKELA S, Karkkainen JM, Eranen J, Siljander A, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27950.
    PubMed     Abstract available


  244. MORRICAL BD, Dearani JA, Cabalka AK
    Melody valve in mitral position: Complete fracture causing acute mitral stenosis in a child.
    Catheter Cardiovasc Interv. 2018 Oct 31. doi: 10.1002/ccd.27683.
    PubMed     Abstract available


  245. ADJEDJ J, Picard F, Mogi S, Iwasaki K, et al
    In vitro flow and optical coherence tomography comparison of two bailout techniques after failed provisional stenting for bifurcation percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27718.
    PubMed     Abstract available


  246. THONGHONG T, Bieliauskas G, De Backer O, Sondergaard L, et al
    Economical cost of percutaneous vascular closure with ProGlide and Prostar XL following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27697.
    PubMed    


  247. AZZALINI L, Uretsky B, Brilakis ES, Colombo A, et al
    Contrast modulation in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Oct 22. doi: 10.1002/ccd.27869.
    PubMed     Abstract available


  248. PINEDA AM, Kevin Harrison J, Kleiman NS, Reardon MJ, et al
    Clinical impact of baseline chronic kidney disease in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 20. doi: 10.1002/ccd.27928.
    PubMed     Abstract available


  249. SPIEKER M, Hellhammer K, Wiora J, Klose S, et al
    Prognostic value of impaired hepato-renal function assessed by the MELD-XI score in patients undergoing percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2018 Oct 17. doi: 10.1002/ccd.27906.
    PubMed     Abstract available


  250. LI J, Patel SM, Nadeem F, Thakker P, et al
    Impact of residual coronary atherosclerosis on transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27894.
    PubMed     Abstract available


  251. KUMAR A, Sato K, Banerjee K, Narayanswami J, et al
    Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Catheter Cardiovasc Interv. 2018 Oct 12. doi: 10.1002/ccd.27927.
    PubMed     Abstract available


  252. MISUMIDA N, Pagath M, Ogunbayo GO, Wilson RE, et al
    Characteristics of and current practice patterns of pacing for high-degree atrioventricular block after transcatheter aortic valve implantation in comparison to surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 9. doi: 10.1002/ccd.27915.
    PubMed     Abstract available


  253. NELSON BC, Chadderdon S, Song H, Zahr FE, et al
    Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27721.
    PubMed     Abstract available


  254. WELT FGP, Klein LW, Tamis-Holland J, Blankenship J, et al
    Views of Appropriate Use Criteria for catheterization and percutaneous coronary revascularization by practicing interventional cardiologists: Results of a survey of American College of Cardiology Interventional Section members.
    Catheter Cardiovasc Interv. 2018 Oct 8. doi: 10.1002/ccd.27931.
    PubMed     Abstract available


  255. STAHLI BE, Wischnewsky MB, Jakob P, Klingenberg R, et al
    Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography.
    Catheter Cardiovasc Interv. 2018 Oct 5. doi: 10.1002/ccd.27712.
    PubMed     Abstract available


  256. FELDMANN K, Cami E, Safian RD
    Planning percutaneous coronary interventions using computed tomography angiography and fractional flow reserve-derived from computed tomography: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2018 Oct 4. doi: 10.1002/ccd.27817.
    PubMed     Abstract available


  257. CASE BC, Geiser KM, Torguson R, Pichard AD, et al
    Comparison of coronary revascularization appropriateness for non-acute coronary syndrome cases under the 2017 update vs the 2012 appropriate use criteria.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27895.
    PubMed     Abstract available


  258. BUCHANAN KD, Rogers T, Steinvil A, Koifman E, et al
    Role of contractile reserve as a predictor of mortality in low-flow, low-gradient severe aortic stenosis following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Oct 2. doi: 10.1002/ccd.27914.
    PubMed     Abstract available


    September 2018
  259. RAWASIA WF, Khan MS, Usman MS, Siddiqi TJ, et al
    Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27840.
    PubMed     Abstract available


  260. BONIN M, Guerin P, Olive JM, Jordana F, et al
    Standardized bench test evaluation of coronary stents: Biomechanical characteristics.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27912.
    PubMed     Abstract available


  261. MORI M, Bin Mahmood SU, Geirsson A, Yun JJ, et al
    Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27855.
    PubMed     Abstract available


  262. SAITO Y, Kitahara H, Okuya Y, Nakayama T, et al
    Novel predictor of target vessel revascularization after coronary stent implantation: Intraluminal intensity of blood speckle on intravascular ultrasound.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27859.
    PubMed     Abstract available


  263. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Abstract available


  264. EDRIS A, Bartel T, Tuzcu EM, Suri RM, et al
    Alcohol septal ablation for outflow tract obstruction after transcatheter aortic and mitral valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27723.
    PubMed     Abstract available


  265. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Abstract available


  266. SHAH R, Jovin IS, Chaudhry A, Haji SA, et al
    Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27828.
    PubMed     Abstract available


  267. DENEGRI A, Mehran R, Holy E, Taramasso M, et al
    Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome
    Catheter Cardiovasc Interv. 2018 Sep 30:e27806. doi: 10.1002/ccd.27806.
    PubMed     Abstract available


  268. MADUKAUWA-DAVID ID, Midha PA, Sharma R, McLain K, et al
    Characterization of aortic root geometry in transcatheter aortic valve replacement patients.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27805.
    PubMed     Abstract available


  269. BAVARIA JE, Tommaso CL, Brindis RG, Carroll JD, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement.
    Catheter Cardiovasc Interv. 2018 Sep 28. doi: 10.1002/ccd.27811.
    PubMed    


  270. FUKUTOMI M, Toriumi S, Ogoyama Y, Oba Y, et al
    Outcome of staged percutaneous coronary intervention within two weeks from admission in patients with ST-segment elevation myocardial infarction with multivessel disease.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27896. doi: 10.1002/ccd.27896.
    PubMed     Abstract available


  271. GARCIA S, Mbai M, Kelly R, Bertog S, et al
    Simultaneous transfemoral transcatheter aortic valve replacement and trans-septal mitral valve-in-ring implantation after partial laceration of an Alfieri stitch.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27875.
    PubMed     Abstract available


  272. KIMURA T, Nishibori Y, Miki K, Maruyama T, et al
    Open sesame technique in percutaneous coronary intervention for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27787.
    PubMed     Abstract available


  273. PIAYDA K, Hellhammer K, Veulemans V, Zeus T, et al
    Valvuloplasty balloon entrapment in a self-expanding aortic valve stent frame after inadvertent wire passage through the outflow struts.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27858.
    PubMed     Abstract available


  274. LAZKANI M, Sawant AC, Taase A, Khan S, et al
    Left atrial hemodynamics and left ventricular remodeling -predictors of outcomes after Transcatheter mitral valve repair with the MitraClip device.
    Catheter Cardiovasc Interv. 2018 Sep 23:e27804. doi: 10.1002/ccd.27804.
    PubMed     Abstract available


  275. KUME T, Yamada R, Koyama T, Tamada T, et al
    Coronary bifurcation bench test using multimodality imaging: Impact of stent strut link location on stent deformity and jailed side-branch orifices during re-proximal optimizing technique.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27719.
    PubMed     Abstract available


  276. RAPHAEL CE, Malouf JF, Maor E, Panaich SS, et al
    A hybrid technique for treatment of commissural primary mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 23. doi: 10.1002/ccd.27904.
    PubMed     Abstract available


  277. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
    Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
    PubMed     Abstract available


  278. SHAUKAT A, Mooney M, Burke MN, Brilakis ES, et al
    Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27868.
    PubMed     Abstract available


  279. RASHID HN, Nasis A, Gooley RP, Cameron JD, et al
    The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27702.
    PubMed     Abstract available


  280. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
    Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
    PubMed     Abstract available


  281. BOI A, Sanna F, Rossi A, Loi B, et al
    Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
    PubMed     Abstract available


  282. VAN MOURIK MS, Janmaat YC, van Kesteren F, Vendrik J, et al
    CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27823.
    PubMed     Abstract available


  283. BUTERA G, Mansour NB, De Marco F
    Emergency trans-catheter coronary intervention for left main compression secondary to pulmonary hypertension in a 4-year-old child.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27796.
    PubMed     Abstract available


  284. RAFIQ A, Chutani S, Krim NR
    Coronary intervention and arteria lusoria-Not simple as it may seem.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27803.
    PubMed     Abstract available


  285. BRUGALETTA S, Cequier A, Alfonso F, Iniguez A, et al
    MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27825.
    PubMed     Abstract available


  286. BRAUN D, Nabauer M, Massberg S, Hausleiter J, et al
    One-stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge-to-edge repair in a patient with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27848.
    PubMed     Abstract available


    August 2018
  287. GURM HS, Seth M, Dixon SR, Michael Grossman P, et al
    Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27819.
    PubMed     Abstract available


  288. AZIZ M, Simonato M, Webb JG, Abdel-Wahab M, et al
    Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID).
    Catheter Cardiovasc Interv. 2018 Aug 5. doi: 10.1002/ccd.27714.
    PubMed     Abstract available


  289. KHAN JM, Lederman RJ
    Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2018;92:388-389.
    PubMed    


  290. CHATTERJEE A, Hillegass WB
    Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
    Catheter Cardiovasc Interv. 2018;92:431-432.
    PubMed    


    July 2018
  291. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Abstract available


  292. CHEN GC, Lu XM, Song YM, Gyawail L, et al
    A 3-year experience of a simple, novel technique for accurate ostial/non-ostial coronary stenting: The buddy balloon anchor stent technique.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27667.
    PubMed     Abstract available


  293. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Abstract available


  294. SMILOWITZ NR, Mohananey D, Razzouk L, Weisz G, et al
    Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27673.
    PubMed     Abstract available


  295. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Abstract available


  296. WUSTROW I, Sarafoff N, Haller B, Rossner L, et al
    Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27678.
    PubMed     Abstract available


  297. RILEY RF, McCabe JM, Kalra S, Lazkani M, et al
    Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27679.
    PubMed     Abstract available


  298. UESHIMA D, Nai Fovino L, Mojoli M, Napodano M, et al
    The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27681.
    PubMed     Abstract available


  299. MAKKI N, Ghao X, Whitson B, Shreenivas S, et al
    Slope of left ventricular filling as an index of valvular and paravalvular regurgitation in native and prosthetic aortic valves.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27684.
    PubMed     Abstract available


  300. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Abstract available


  301. SHLOFMITZ E, Jeremias A
    Precision percutaneous coronary intervention: Is optical coherence tomography co-registration the future?
    Catheter Cardiovasc Interv. 2018;92:38-39.
    PubMed     Abstract available


    June 2018
  302. BLOCK PC
    Transcatheter treatment of aortic regurgitation: Still enigmatic.
    Catheter Cardiovasc Interv. 2018;91:1352-1353.
    PubMed     Abstract available


    May 2018
  303. HACHINOHE D, Latib A, Montorfano M, Colombo A, et al
    Transcatheter mitral valve implantation in rigid mitral annuloplasty rings: Potential differences between complete and incomplete rings.
    Catheter Cardiovasc Interv. 2018 May 18. doi: 10.1002/ccd.27658.
    PubMed     Abstract available


  304. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed    


  305. JACKSON M, Austin D, Kwok CS, Rashid M, et al
    The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27642.
    PubMed     Abstract available


  306. TAMEZ H, Genereux P, Yeh RW, Amin AP, et al
    Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638.
    PubMed     Abstract available


    April 2018
  307. SETO AH, Shroff A, Abu-Fadel M, Blankenship JC, et al
    Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions.
    Catheter Cardiovasc Interv. 2018 Apr 24. doi: 10.1002/ccd.27637.
    PubMed     Abstract available


  308. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed    


  309. DE BACKER O, Sondergaard L
    TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions.
    Catheter Cardiovasc Interv. 2018;91:984-985.
    PubMed     Abstract available


  310. KRISHNAN SK, Dean LS
    Looking for the bare necessities.
    Catheter Cardiovasc Interv. 2018;91:956-957.
    PubMed     Abstract available


  311. BURZOTTA F, Trani C
    TAVR technique tries to go higher than bicuspid valve hurdles.
    Catheter Cardiovasc Interv. 2018;91:995-996.
    PubMed     Abstract available


  312. TURI ZG
    The under-appreciated and still under-investigated consequences of "supersized" access and closure.
    Catheter Cardiovasc Interv. 2018;91:945-946.
    PubMed     Abstract available


    March 2018
  313. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed    


  314. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Abstract available


  315. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Abstract available


  316. YE J, Lee AJ, Blanke P, Webb J, et al
    The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27604.
    PubMed     Abstract available


  317. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Abstract available


  318. GOINS AE, Rayson R, Caughey MC, Sola M, et al
    Correlation of infarct size with invasive hemodynamics in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27625.
    PubMed     Abstract available


  319. MOHDNAZRI SR, Karamasis GV, Al-Janabi F, Cook CM, et al
    The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO.
    Catheter Cardiovasc Interv. 2018 Mar 22. doi: 10.1002/ccd.27587.
    PubMed     Abstract available


  320. TAKAHASHI M, Badenco N, Monteau J, Gandjbakhch E, et al
    Impact of pacemaker mode in patients with atrioventricular conduction disturbance after trans-catheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Mar 14. doi: 10.1002/ccd.27594.
    PubMed     Abstract available


  321. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Abstract available


  322. ABDELGHANI M, de Winter RJ, Miyazaki Y, Modolo R, et al
    Determinants of success and hemodynamic impact of balloon postdilatation of self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27538.
    PubMed     Abstract available


  323. NIIDA T, Murai T, Yonetsu T, Kanaji Y, et al
    Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
    Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27570.
    PubMed     Abstract available


  324. ANANTHAKRISHNA R, Kristanto W, Liu L, Chan SP, et al
    Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27577.
    PubMed     Abstract available


  325. GOLDSWEIG AM, Wang Y, Forrest JK, Cleman MW, et al
    Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999-2014.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27576.
    PubMed     Abstract available


  326. XIE R, Hillegass WB
    Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
    Catheter Cardiovasc Interv. 2018;91:696.
    PubMed     Abstract available


  327. TAJTI P, Karmpaliotis D, Alaswad K, Toma C, et al
    Prevalence, Presentation and Treatment of 'Balloon Undilatable' Chronic Total Occlusions: Insights from a Multicenter US Registry.
    Catheter Cardiovasc Interv. 2018;91:657-666.
    PubMed     Abstract available


  328. TAKAGI H, Ando T, Umemoto T
    Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease.
    Catheter Cardiovasc Interv. 2018;91:697-709.
    PubMed     Abstract available


  329. MIZOTE I, Schirmer J, Schafer U
    A case of successful Mitraclip implantation in a patient having a large coaptation gap under extracorporeal membrane oxygenation (ECMO).
    Catheter Cardiovasc Interv. 2018;91:827-830.
    PubMed     Abstract available


    February 2018
  330. DAUTOV R, Ybarra LF, Nguyen CM, Gibrat C, et al
    Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27545.
    PubMed     Abstract available


  331. SARAF S, Cockburn J, Alsanjari O, Hildick-Smith D, et al
    Transcatheter aortic valve implantation via the superficial femoral artery: An underused access route?
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27544.
    PubMed     Abstract available


  332. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Abstract available


  333. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Abstract available


  334. MURAI T, Yonetsu T, Kanaji Y, Usui E, et al
    Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2018 Feb 15. doi: 10.1002/ccd.27529.
    PubMed     Abstract available


  335. BENSON L
    PPVI in children under 20 kilograms: A quid pro quo?
    Catheter Cardiovasc Interv. 2018;91:495-496.
    PubMed     Abstract available


  336. MARTIN MH, Shahanavaz S, Peng LF, Asnes JD, et al
    Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg.
    Catheter Cardiovasc Interv. 2018;91:485-494.
    PubMed     Abstract available


  337. GASPARINI GL, Oreglia JA, Reimers B
    Self-apposing stent-assisted coil embolization for the treatment of coronary artery aneurysm.
    Catheter Cardiovasc Interv. 2018;91:470-474.
    PubMed     Abstract available


  338. WALDO SW, O'Donnell CI, Prouse A, Plomondon ME, et al
    Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program.
    Catheter Cardiovasc Interv. 2018;91:425-433.
    PubMed     Abstract available


  339. ADJEDJ J, Toth GG, Pellicano M, Wijns W, et al
    Reversed single string technique for coronary bifurcation stenting-First report of case demonstrations in vitro.
    Catheter Cardiovasc Interv. 2018;91:396-401.
    PubMed     Abstract available


  340. VAN BOMMEL RJ, Lemmert ME, van Mieghem NM, van Geuns RJ, et al
    Occurrence and predictors of acute stent recoil-A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent.
    Catheter Cardiovasc Interv. 2018;91:E21-E28.
    PubMed     Abstract available


  341. CAMPOS CM, Caixeta A, Franken M, Bartorelli AL, et al
    Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND an
    Catheter Cardiovasc Interv. 2018;91:387-395.
    PubMed     Abstract available


  342. GASIOR P, Cheng Y, Estrada EA, Jenn McGregor, et al
    Novel ultrahigh molecular weight amorphous PLLA bioresorbable coronary scaffold upsized up to 0.8 mm beyond nominal diameter: An OCT and histopathology study in porcine coronary artery model.
    Catheter Cardiovasc Interv. 2018;91:378-386.
    PubMed     Abstract available


  343. BAILEY SR
    Catheterization and Cardiovascular Interventions CIT Special Issue: Editor In Chief Editorial.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed    


  344. MEHRAN R
    The History of Clinical Research Workshop at CIT: A Ten Year Perspective.
    Catheter Cardiovasc Interv. 2018;91.
    PubMed    


  345. ZIVELONGHI C, van Kuijk JP, Nijenhuis V, Poletti E, et al
    First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539.
    PubMed     Abstract available


  346. MCNEICE AH, Brooks M, Hanratty CG, Stevenson M, et al
    A retrospective study of radiation dose measurements comparing different cath lab X-ray systems in a sample population of patients undergoing percutaneous coronary intervention for chronic total occlusions.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27541.
    PubMed     Abstract available


  347. SAWANT AC, Bhardwaj A, Banerjee K, Jobanputra Y, et al
    Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27525.
    PubMed     Abstract available


  348. FACCINI A, Butera G
    Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27527.
    PubMed     Abstract available


  349. LIU X, He Y, Zhu Q, Gao F, et al
    Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2018 Feb 5. doi: 10.1002/ccd.27467.
    PubMed     Abstract available


  350. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Abstract available


  351. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Abstract available


  352. HEUSER RR
    Perforations and how to manage: The coronary interventionalist and peripheral interventionalist working together for a solution.
    Catheter Cardiovasc Interv. 2018;91:308-309.
    PubMed     Abstract available


  353. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Abstract available


  354. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Abstract available


  355. TAN C, Dean LS
    Conscious sedation for TAVR: A wave of the future?
    Catheter Cardiovasc Interv. 2018;91:343-344.
    PubMed     Abstract available


  356. DI MARIO C, Sorini Dini C
    Maximal efficiency is required to minimize complications and hospital stay after TAVR.
    Catheter Cardiovasc Interv. 2018;91:354-355.
    PubMed     Abstract available


  357. SCHNEIDER HE, Gravenhorst V, Paul T, Jacobshagen C, et al
    Insufficiency of a Damus-Kaye-Stansel anastomosis in a Fontan patient: Transfemoral implantation of an Edwards Sapien 3 valve.
    Catheter Cardiovasc Interv. 2018;91:292-295.
    PubMed     Abstract available


  358. LLURI G, Levi DS, Miller E, Hageman A, et al
    Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2018;91:277-284.
    PubMed     Abstract available


  359. MCGARVEY M, Ali O, Iqbal MB, Ilsley C, et al
    A feasibility and safety study of intracoronary hemodilution during primary coronary angioplasty in order to reduce reperfusion injury in myocardial infarction.
    Catheter Cardiovasc Interv. 2018;91:234-241.
    PubMed     Abstract available


  360. SARDAR P, Kundu A, Bischoff M, Chatterjee S, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis.
    Catheter Cardiovasc Interv. 2018;91:203-212.
    PubMed     Abstract available


    January 2018
  361. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Abstract available


  362. BADRI M, Shapiro T, Wang Y, Minges KE, et al
    Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27490.
    PubMed     Abstract available


  363. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Abstract available


  364. SCHAFER U, Kalbacher D, Voigtlander L, Conradi L, et al
    First-in-human implantation of a novel self-expanding supra-annular transcatheter heart valve for transcatheter aortic valve implantation inside a small degenerated aortic surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27466.
    PubMed     Abstract available


  365. TSURUTA H, Hayashida K, Yashima F, Yanagisawa R, et al
    Incidence, predictors, and midterm clinical outcomes of left ventricular obstruction after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27508.
    PubMed     Abstract available


  366. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Abstract available


  367. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Abstract available


  368. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Abstract available


  369. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Abstract available


  370. MALIK SA, Brilakis ES, Pompili V, Chatzizisis YS, et al
    Lost and found: Coronary stent retrieval and review of literature.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27464.
    PubMed     Abstract available


  371. IVERSON A, Stanberry L, Garberich R, Antos A, et al
    Impact of sleep deprivation on the outcomes of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27471.
    PubMed    


  372. AMAT-SANTOS IJ, Rojas P, Gutierrez H, Vera S, et al
    Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27485.
    PubMed     Abstract available


  373. ROGERS T, Lederman RJ
    Percutaneous transaxillary access for TAVR: Another opportunity to stay out of the chest.
    Catheter Cardiovasc Interv. 2018;91:157-158.
    PubMed     Abstract available


  374. AUBERSON D, Gray W
    Good enough...isn't.
    Catheter Cardiovasc Interv. 2018;91:148-149.
    PubMed     Abstract available


  375. VO MN, Brilakis ES, Grantham JA
    Novel use of cutting balloon to treat subintimal hematomas during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2018;91:53-56.
    PubMed     Abstract available


  376. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Fracturing a dysfunctional Edwards Perimount bioprosthetic valve to facilitate percutaneous valve-in-valve placement of SAPIEN 3 valve with modified delivery system.
    Catheter Cardiovasc Interv. 2018;91:81-85.
    PubMed     Abstract available


  377. BOUDJEMLINE Y
    A new one-step procedure for pulmonary valve implantation of the melody valve: Simultaneous prestenting and valve implantation.
    Catheter Cardiovasc Interv. 2018;91:64-70.
    PubMed     Abstract available


  378. GASPARINI GL, Oreglia JA, Garbo R
    The trap and occlude technique for retrograde wire externalization during chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2018;91:57-63.
    PubMed     Abstract available


  379. CAPRETTI G, Carlino M, Colombo A, Azzalini L, et al
    Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further.
    Catheter Cardiovasc Interv. 2018;91:47-52.
    PubMed     Abstract available


  380. GOLESKI PJ, Reisman M, Don CW
    Reversible thrombotic aortic valve restenosis after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018;91:165-168.
    PubMed     Abstract available


  381. NERLA R, Cremonesi A, Castriota F
    Successful percutaneous paravalvular leak closure followed by transfemoral aortic lotus valve-in-valve implantation in a degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2018;91:169-174.
    PubMed     Abstract available


    December 2017
  382. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Abstract available


  383. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Abstract available


  384. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Abstract available


  385. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Abstract available


  386. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Abstract available


  387. SHATILA W, Krajcer Z
    A cardiologist's nightmare: Coronary obstruction during transcatheter aortic valve implantation: How to identify patients at highest risk for this complication.
    Catheter Cardiovasc Interv. 2017;90:1198-1199.
    PubMed     Abstract available


    November 2017
  388. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Abstract available


  389. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Abstract available


  390. SILASCHI M, Conradi L, Wendler O, Schlingloff F, et al
    The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27370.
    PubMed     Abstract available


  391. THEUERLE J, Yudi MB, Farouque O, Andrianopoulos N, et al
    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Catheter Cardiovasc Interv. 2017 Nov 15. doi: 10.1002/ccd.27411.
    PubMed     Abstract available


  392. MURATA N, Takayama T, Hiro T, Hirayama A, et al
    Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2017 Nov 13. doi: 10.1002/ccd.27405.
    PubMed     Abstract available


  393. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Abstract available


  394. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Abstract available


  395. SCHOECHLIN S, Brennemann T, Allali A, Ruile P, et al
    Hemodynamic classification of paravalvular leakage after transcatheter aortic valve implantation compared with angiographic or echocardiographic classification for prediction of 1-year mortality.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27384.
    PubMed     Abstract available


    October 2017
  396. BARAN DA, Visveswaran GK, Seliem A, DiVita M, et al
    Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27387.
    PubMed     Abstract available


  397. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed    


  398. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Abstract available


  399. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Abstract available


  400. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Abstract available


  401. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Abstract available


  402. STEINBERG ZL, Morray BH, Jones TK
    Bicaval Medtronic Melody valve implantation for treatment of severe mitral regurgitation following the Mustard repair: A case report.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27373.
    PubMed     Abstract available


  403. FLUECKIGER P, Singleton M, Vasu S, Zhao D, et al
    Bioprosthetic tricuspid valve thrombosis: Percutaneous PFO closure to improve hypoxia and respiratory failure.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27217.
    PubMed     Abstract available


  404. LEE MS, Gordin JS, Stone GW, Sharma SK, et al
    Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification.
    Catheter Cardiovasc Interv. 2017 Oct 17. doi: 10.1002/ccd.27339.
    PubMed     Abstract available


  405. O'NEILL J, Hogarth AJ, Pearson I, Law H, et al
    Transcoronary pacing to assess myocardial viability prior to percutaneous coronary intervention: Pilot study to assess feasibility.
    Catheter Cardiovasc Interv. 2017 Oct 16. doi: 10.1002/ccd.27349.
    PubMed     Abstract available


  406. LANDES U, Bental T, Levi A, Assali A, et al
    Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.
    Catheter Cardiovasc Interv. 2017 Oct 13. doi: 10.1002/ccd.27375.
    PubMed     Abstract available


  407. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Abstract available


  408. LIANG M, Yang S, Fu N, Lu C, et al
    Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
    PubMed     Abstract available


  409. RUPARELIA N, Cao J, Newton JD, Wilson N, et al
    Paravalvular leak closure under intracardiac echocardiographic guidance.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27318.
    PubMed     Abstract available


  410. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Abstract available


  411. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Abstract available


  412. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Abstract available


  413. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Abstract available


  414. ENEZATE T, Omran J, Al-Dadah AS, Alpert M, et al
    Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27302.
    PubMed     Abstract available


  415. FRANKEN M, Lemos PA
    Treating of aortic valve stenosis in real-life: A multifaceted decision-making challenge.
    Catheter Cardiovasc Interv. 2017;90:671-672.
    PubMed     Abstract available


    September 2017
  416. LIANG FW, Lee JC, Lu TH, Yin WH, et al
    Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27343.
    PubMed     Abstract available


  417. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Abstract available


  418. IQBAL MB, Smith RD, Lane R, Patel N, et al
    The prognostic significance of incomplete revascularization and untreated coronary anatomy following percutaneous coronary intervention: An analysis of 6,755 patients with multivessel disease.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27331.
    PubMed     Abstract available


  419. ANDO T, Briasoulis A, Telila T, Afonso L, et al
    Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27336.
    PubMed     Abstract available


  420. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Abstract available


  421. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Abstract available


  422. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Abstract available


  423. AIT ICHOU J, Larivee N, Eisenberg MJ, Suissa K, et al
    The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27316.
    PubMed     Abstract available


  424. LEISTNER DM, Riedel M, Steinbeck L, Stahli BE, et al
    Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27313.
    PubMed     Abstract available


  425. GIANNINI F, Latib A, Montorfano M, Ruparelia N, et al
    A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27319.
    PubMed     Abstract available


  426. BOEHNEL C, Rickli H, Graf L, Maeder MT, et al
    Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27255.
    PubMed     Abstract available


  427. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Abstract available


  428. SONG Y, Gao Z, Tang X, Ma Y, et al
    Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27321.
    PubMed     Abstract available


  429. YAHAGI K, Torii S, Ladich E, Kutys R, et al
    Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314.
    PubMed     Abstract available


  430. ANDO T, Takagi H, Briasoulis A, Telila T, et al
    A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions.
    Catheter Cardiovasc Interv. 2017 Sep 1. doi: 10.1002/ccd.27256.
    PubMed     Abstract available


    August 2017
  431. DHOBLE A, Bhise V, Nevah MI, Balan P, et al
    Outcomes and readmissions after transcatheter and surgical aortic valve replacement in patients with cirrhosis: A propensity matched analysis.
    Catheter Cardiovasc Interv. 2017 Aug 28. doi: 10.1002/ccd.27232.
    PubMed     Abstract available


  432. HUCZEK Z, Zbronski K, Grodecki K, Scislo P, et al
    Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL-TAVI Registry.
    Catheter Cardiovasc Interv. 2017 Aug 26. doi: 10.1002/ccd.27251.
    PubMed     Abstract available


  433. ALKHALIL A, Lamba H, Deo S, Bezerra HG, et al
    Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 24. doi: 10.1002/ccd.27230.
    PubMed     Abstract available


  434. KRISHNAN S, Daniels D, McCabe JM
    Novel bipolar preshaped left ventricular pacing wire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 11. doi: 10.1002/ccd.27244.
    PubMed    


  435. BHARADWAJ AS, Bhatheja S, Sharma SK, Kini AS, et al
    Utility of the guideliner catheter for percutaneous coronary interventions in patients with prior transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Aug 10. doi: 10.1002/ccd.27211.
    PubMed     Abstract available


  436. FELDMAN T, Guerrero M
    Balloon aortic valvuloplasty in the TAVR era: Not so new but definitely improved.
    Catheter Cardiovasc Interv. 2017;90:311-312.
    PubMed     Abstract available


    July 2017
  437. VILLABLANCA PA, Mohananey D, Nikolic K, Bangalore S, et al
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2017 Jul 24. doi: 10.1002/ccd.27207.
    PubMed     Abstract available


  438. CLAESSEN BE, van den Boogert TPW, Piek JJ
    Recurrent myocardial infarction in a 47-year-old woman with a mechanical mitral valve prosthesis: Atherosclerosis, embolism, or spasm?
    Catheter Cardiovasc Interv. 2017 Jul 12. doi: 10.1002/ccd.27186.
    PubMed     Abstract available


    June 2017
  439. KOEHLE M, Strote JA, Guadagnoli M, Oldemeyer JB, et al
    A novel mechanical mitral valve replacement using Sapien XT.
    Catheter Cardiovasc Interv. 2017 Jun 9. doi: 10.1002/ccd.27149.
    PubMed     Abstract available


  440. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Abstract available


  441. CARRERAS ET, Barghash M, Givertz MM, Bhatt DL, et al
    A heart within a heart.
    Catheter Cardiovasc Interv. 2017;89:1239-1241.
    PubMed     Abstract available


  442. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Abstract available


  443. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Abstract available


  444. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Abstract available


  445. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Abstract available


  446. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Abstract available


  447. ORVIN K, Kornowski R
    The problem of delirium following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017;89:1292-1293.
    PubMed     Abstract available


    May 2017
  448. DOERNER J, Kupczyk PA, Wilsing M, Luetkens JA, et al
    Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2017 May 26. doi: 10.1002/ccd.27122.
    PubMed     Abstract available


  449. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Abstract available


  450. TARAMASSO M, Denegri A, Kuwata S, Rickli H, et al
    Feasibility and safety of transfemoral sheathless portico aortic valve implantation: Preliminary results in a single center experience.
    Catheter Cardiovasc Interv. 2017 May 13. doi: 10.1002/ccd.27100.
    PubMed     Abstract available


  451. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Abstract available


  452. BRUNNER NW, Yue SF, Stub D, Ye J, et al
    The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
    PubMed     Abstract available


  453. SALNA M, Khalique OK, Chiuzan C, Kurlansky P, et al
    Impact of small prosthesis size on transcatheter or surgical aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27120.
    PubMed     Abstract available


  454. OKOH AK, Chauhan D, Kang N, Haik N, et al
    The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
    PubMed     Abstract available


  455. MORIYAMA N, Tanaka Y, Saito S
    Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
    Catheter Cardiovasc Interv. 2017;89:1022-1027.
    PubMed     Abstract available


  456. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
    Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
    Catheter Cardiovasc Interv. 2017;89:984-991.
    PubMed     Abstract available


    April 2017
  457. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
    Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
    PubMed     Abstract available


  458. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
    Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
    Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
    PubMed     Abstract available


    March 2017
  459. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
    Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
    Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
    PubMed     Abstract available


  460. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
    First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
    PubMed     Abstract available


  461. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
    Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
    PubMed     Abstract available


  462. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
    Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
    PubMed     Abstract available


  463. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
    Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
    PubMed     Abstract available


  464. ARAI T, Lefevre T, Hovasse T, Garot P, et al
    Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
    Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
    PubMed     Abstract available


  465. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
    Early readmissions after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
    PubMed     Abstract available


    February 2017
  466. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
    End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
    PubMed     Abstract available


  467. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
    Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
    PubMed     Abstract available


  468. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
    Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
    PubMed     Abstract available


  469. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
    Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
    PubMed     Abstract available


    January 2017
  470. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
    Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
    Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
    PubMed     Abstract available


  471. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
    Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
    Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
    PubMed     Abstract available


    December 2016
  472. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
    Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
    PubMed     Abstract available


    November 2016
  473. FETTERLY K, Greason K, Mathew V
    Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
    Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
    PubMed     Abstract available


  474. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
    Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
    Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
    PubMed     Abstract available


  475. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
    Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
    PubMed     Abstract available


  476. LEHNER A, Ulrich S, Happel CM, Fischer M, et al
    Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech(R) PDA occluder.
    Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26856.
    PubMed     Abstract available


    October 2016
  477. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
    Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
    PubMed     Abstract available


  478. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
    Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
    PubMed     Abstract available


  479. LANDES U, Sagie A, Kornowski R
    Transcatheter aortic valve implantation in degenerative sutureless perceval aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26576.
    PubMed     Abstract available


    September 2016
  480. ACHARJI S, Agnihotri A, Carrozza J
    Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
    Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
    PubMed     Abstract available


  481. HARPER AR, Dawkins S, Newton JD
    Late subannular aortic root rupture following transcatheter aortic valve implantation presenting as ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016 Sep 21. doi: 10.1002/ccd.26724.
    PubMed     Abstract available


  482. OKUYAMA K, Chakravarty T, Makkar RR
    Percutaneous transapical pseudoaneurysm closure following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Sep 13. doi: 10.1002/ccd.26494.
    PubMed     Abstract available


    August 2016
  483. HUDED CP, Huded JM, Sweis RN, Ricciardi MJ, et al
    The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26776.
    PubMed     Abstract available


  484. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
    Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
    PubMed     Abstract available


  485. ROGGEN M, Dubois C, Gewillig M
    Coronary artery stenting in a patient with progeria.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
    PubMed     Abstract available


  486. AIRHART S, Medvedev I, Dean LS
    Relative prosthesis-patient mismatch after transcatheter aortic valve replacement: The impact of morbid obesity.
    Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26721.
    PubMed     Abstract available


  487. NAKAMURA K, Passeri JJ, Inglessis-Azuaje I
    Percutaneous closure of acute aorto-right ventricular fistula following transcatheter bicuspid aortic valve replacement.
    Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26705.
    PubMed     Abstract available


  488. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
    Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
    Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
    PubMed     Abstract available


  489. FERRERA C, Nombela-Franco L, Garcia E, Jimenez-Quevedo P, et al
    Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
    Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26671.
    PubMed     Abstract available


    July 2016
  490. MANOLY I, Hasan R, Brazier A, Farooq V, et al
    Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
    PubMed     Abstract available


  491. STANGER DE, Abdulla AH, Wong FT, Alipour S, et al
    Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.
    Catheter Cardiovasc Interv. 2016 Jul 9. doi: 10.1002/ccd.26650.
    PubMed     Abstract available


    June 2016
  492. TRAYNOR MM, Greason KL, Nkomo VT, Pochettino A, et al
    Assisted care as a baseline patient risk characteristic affecting the outcome of transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2016 Jun 8. doi: 10.1002/ccd.26580.
    PubMed     Abstract available


    March 2016
  493. CHAN AW, Wong D, Charania J
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis Using Lotus Valve System.
    Catheter Cardiovasc Interv. 2016 Mar 31. doi: 10.1002/ccd.26506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: